Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Pomegranate Health vs VigorMeds

Pomegranate Health
Graded #128

Higher grade

vs+17.700000000000003
VigorMeds
Graded #484

Lower grade

The verdict

Pomegranate Health takes it — 69.4/100 to 51.7/100.

Pomegranate Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Pomegranate Health sells compounded semaglutide and tirzepatide with no membership and no consultation fee.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePomegranate Health +35
80
45
Dose & formulationPomegranate Health +24
64
40
Clinical oversightPomegranate Health +12
82
70
Labs & monitoringEven
53
53
FulfillmentPomegranate Health +5
65
60
Contract termsPomegranate Health +14
55
41
Pomegranate Health · left barVigorMeds · right bar

The numbers

MetricPomegranate HealthVigorMeds
WeighScore69.4/10051.7/100
GradeCC
Scorecard rank#128#484
Semaglutide$119/mo (starting price, compounded)Not disclosed
Tirzepatide$149/mo (Starter tier, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Pomegranate Health

Graded #128 · C

Strengths

  • No membership and no consultation fee — the site states 'No Membership required' and 'Transparent pricing, no hidden fees'
  • The semaglutide price sits in the product page's own static HTML, so it can be read before any intake
  • Shipping is included: 'shipped discreetly to your door at no extra cost'
  • Both semaglutide and tirzepatide are offered

Where it loses points

  • The tirzepatide price is not on the public site at all — it exists only inside the in-app pricing portal, and there is no standalone tirzepatide product page to read it from
  • Both published figures are floors, a 'Starts @' and a Starter tier, and no price is published for the dose you titrate up to
  • The states it can prescribe in are not disclosed anywhere; the dataset's own note records that semaglutide was unavailable in CA, IA and WI
  • Klarna, Afterpay and Affirm are offered at checkout, so any monthly figure seen in a financing widget is an instalment and not the medication price
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
VigorMeds

Graded #484 · C

Strengths

  • Provider-guided GLP-1 weight management via a telehealth consultation, not a pure async questionnaire
  • Care delivered by named, experienced clinicians (Dr. Anthony Kane, Dr. Kevin Kargman, Stephanie Kowatch FNP-C)
  • No-questions-asked 30-day satisfaction guarantee
  • Multi-vertical platform — also offers anti-aging/wellness, ED, and hair-loss treatment
  • Personalized treatment plan with ongoing follow-up and support

Where it loses points

  • Pricing not shown until you create an account and complete the intake
  • Specific GLP-1 medications and forms are not named on the public site
  • States served are not listed on an accessible page
  • Vigormeds LLC is a patient-management platform; prescribing is via OLA Health LLC and independent providers
  • No LegitScript certification or pharmacy-partner details published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard